Back to search

Article

The expression of PD-1 ligands in the immune microenvironment was altered in TTF-1-negative lung adenocarcinoma

2025-04-17

Abstract excerpt

<title>Abstract</title> <p><italic><bold>Background:</bold></italic><italic> </italic>Immunotherapies targeting the programmed cell death-1 (PD-1) pathway have been adopted in lung adenocarcinoma (LUAD) treatment. Expression of programmed cell death-ligand 1 (PD-L1) and PD-L2 is observed in both cancer cells and tumor-associated macrophages (TAMs). PD-L1/L2 expression in TAMs is thought to be induced by inflammat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
abaa07fd-9f39-50ec-936f-d60c83547a89
DOI
10.21203/rs.3.rs-6311106/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The expression of PD-1 ligands in the immune microenvironment was altered in TTF-1-negative lung adenocarcinomaDOI 10.21203/rs.3.rs-6311106/v1
TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors.Semantic proximity
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer.Semantic proximity
Relationship of tumor PD-L1 expression with<i>EGFR</i>wild-type status and poor prognosis in lung adenocarcinomaSemantic proximity
Multi-Omics reveals SPP1+ Malignant and CXCR4+ TAM crosstalk predicts immunotherapy response in lung adenocarcinoma cancerSemantic proximity
Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinomaSemantic proximity
An Investigation of the Immune Microenvironment and Genome during Lung Adenocarcinoma DevelopmentSemantic proximity
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors.Semantic proximity
Spatially resolved whole-transcriptomic profiling of EGFR-mutated lung adenocarcinomas stratified by PD-L1 expression.Semantic proximity
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.Semantic proximity
TCF-1+ PD-1+ CD8+T Cells Are Associated With The Response To PD-1 Blockade In Non-Small Cell Lung Cancer PatientsSemantic proximity
Who Will Benefit Most From PD-L1 Detection and Immunotherapy in Non-small Cell Lung Cancer?Semantic proximity
Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signatureSemantic proximity
Select a neighboring publication to make it the new centre.